Media mentions

<p>Francesc Posas, director at IRB Barcelona</p>
15 Oct 2018

The campaign for charitable bequests

TV3

TV3 has reported on the campaign "Legado Solidario", an initiative involving 25 organisations, among them IRB Barcelona. In the report, Francesc Posas, director of the institute, talks about the bequest of 1.5 € million the centre received last year to support cancer research and metastasis.

<p>Source: TV3</p>
05 Oct 2018

Scientists identify nanoantibodies in alpacas capable of blocking a protein that is abundant in tumour cells

TV3 & OTHER MEDIA

La Razón, TV3, La Sexta, Men's Health and New Atlas, among other local and international media, have published an article about the study done at IRB Barcelona and Vrije Universiteiti Brussel. The study has identified camelid nanobodies able to block EGF, a protein that is abundant in tumour cells and that helps them to proliferate.

<p>Drosophila epithelium subjected to chromosomal instability (CIN): cells start invading the neighbouring tissues. Magenta labels the nuclei of all the epithelium while green labels the membranes of cells subjected to CIN (L Barrio, IRB Barcelona)</p>
01 Oct 2018

Scientists show that the chromosomal instability of tumours promotes metastasis

LA VANGUARDIA & OTHER MEDIA

La Vanguardia, Biotech, Salud y Medicina, among other media, have published an article on the study led by IRB Barcelona researcher Marco Milán. The study shows that chromosomal instability itself can induce invasive behaviour in epithelial cells, and identifies the underlying molecular mechanisms involved.

Contact

<p>Sonia Armengou</p>
Sònia Armengou
Section Head of Communications
Tel: +34 93 40 37255

Basic information about IRB

Quick facts

IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.

IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.

The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.

Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.

Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.